Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
Clinical trial NCT03862911 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03862911
- Sponsor
- British Columbia Cancer Agency
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2030-11-24
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.